Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 122077
Published online Aug 15, 2026. doi: 10.4251/wjgo.122077
Published online Aug 15, 2026. doi: 10.4251/wjgo.122077
Table 1 Clinicopathologic characteristics of patients, mean ± SD/n (%)
| Variables | Patients (n = 146) |
| Gender | |
| Male | 91 (62.3) |
| Female | 55 (37.7) |
| Age, year | 64.9 ± 9.7 |
| Tumor stage | |
| I | 57 (39.0) |
| II | 41 (28.1) |
| III | 36 (24.7) |
| IV | 12 (8.2) |
| Tumor differentiation | |
| Well | 13 (8.9) |
| Moderate | 91 (62.3) |
| Poor | 42 (28.8) |
| Preoperative therapy | 9 (6.2) |
| Tumor location | |
| Rectum | 65 (44.5) |
| Sigmoid | 52 (35.6) |
| Descending | 14 (9.6) |
| Right colon | 15 (10.3) |
| Surgical approach | |
| Laparoscopic | 114 (78.1) |
| Robotic | 32 (21.9) |
| Number of LNs | 22.0 ± 9.2 |
| Metastatic LNs | 0.9 ± 2.0 |
- Citation: Bai BJ, Xu DY, Chen L, Ding LY, Song ZF. Clinical value of carbon nanoparticles in identifying metastatic lymph nodes in colorectal cancer: A single-center observational study. World J Gastrointest Oncol 2026; 18(8): 122077
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/122077.htm
- DOI: https://dx.doi.org/10.4251/wjgo.122077